CORT

Corcept Therapeutics INC

Insider trading activity for Corcept Therapeutics INC, straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

-$42.6M

net selling

Bought(0 · 0 insiders): $0
Sold(45 · 7 insiders): $42.6M

Past 6 months

-$83M

net selling

Bought(0 · 0 insiders): $0
Sold(92 · 10 insiders): $83M

Past 12 months

-$94.3M

net selling

Bought(2 · 1 insiders): $3.3M
Sold(106 · 10 insiders): $97.6M

Transaction history

The 100 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Nov 3	Maduck Sean	See Remarks	MEXER◷◆	13,159	—	—	—	Open the original filing on SEC.gov
Nov 3	Maduck Sean	See Remarks	SSELL◷	4,542	$82.68	$375.5K	-31.4%	Open the original filing on SEC.gov
Nov 3	Maduck Sean	See Remarks	SSELL◷	8,617	$82.02	$706.8K	-37.3%	Open the original filing on SEC.gov
Nov 3	Maduck Sean	See Remarks	MEXER◷	13,159	$8.27	$108.8K	+132.4%	Open the original filing on SEC.gov
Nov 2	Vieira Roberto Wandenkol…	President, Oncology	MEXER◷◆	8,333	—	—	—	Open the original filing on SEC.gov
Nov 2	Vieira Roberto Wandenkol…	President, Oncology	SSELL◷	1,676	$81.52	$136.6K	-29.8%	Open the original filing on SEC.gov
Nov 2	Vieira Roberto Wandenkol…	President, Oncology	SSELL◷	6,657	$80.73	$537.4K	-54.2%	Open the original filing on SEC.gov
Nov 2	Vieira Roberto Wandenkol…	President, Oncology	MEXER◷	8,333	$21.63	$180.2K	+211.2%	Open the original filing on SEC.gov
Nov 2	Maduck Sean	See Remarks	MEXER◷◆	11,841	—	—	—	Open the original filing on SEC.gov
Nov 2	Maduck Sean	See Remarks	SSELL◷	11,841	$81.42	$964.1K	-54.4%	Open the original filing on SEC.gov
Nov 2	Maduck Sean	See Remarks	MEXER◷	11,841	$8.27	$97.9K	+119.2%	Open the original filing on SEC.gov
Oct 15	Wilson James N	Director	SSELL◷	300	$116.30	$34.9K	<0.1%	Open the original filing on SEC.gov
Oct 15	Wilson James N	Director	SSELL◷	3,046	$115.39	$351.5K	-0.3%	Open the original filing on SEC.gov
Oct 15	Wilson James N	Director	SSELL◷	6,654	$114.48	$761.7K	-0.6%	Open the original filing on SEC.gov
Oct 2	Lyon Joseph Douglas	See Remarks	MEXER◷◆	5,833	—	—	—	Open the original filing on SEC.gov
Oct 2	Lyon Joseph Douglas	See Remarks	MEXER◷◆	3,357	—	—	—	Open the original filing on SEC.gov
Oct 2	Lyon Joseph Douglas	See Remarks	SSELL◷	4,744	$116.54	$552.9K	-45.5%	Open the original filing on SEC.gov
Oct 2	Lyon Joseph Douglas	See Remarks	SSELL◷	4,446	$115.70	$514.4K	-29.9%	Open the original filing on SEC.gov
Oct 2	Lyon Joseph Douglas	See Remarks	MEXER◷	5,833	$19.26	$112.3K	+64.5%	Open the original filing on SEC.gov
Oct 2	Lyon Joseph Douglas	See Remarks	MEXER◷	3,357	$13.56	$45.5K	+59.1%	Open the original filing on SEC.gov
Oct 2	Vieira Roberto Wandenkol…	President, Oncology	MEXER◷◆	8,333	—	—	—	Open the original filing on SEC.gov
Oct 2	Vieira Roberto Wandenkol…	President, Oncology	SSELL◷	5,147	$116.59	$600.1K	-56.6%	Open the original filing on SEC.gov
Oct 2	Vieira Roberto Wandenkol…	President, Oncology	SSELL◷	2,086	$115.73	$241.4K	-18.7%	Open the original filing on SEC.gov
Oct 2	Vieira Roberto Wandenkol…	President, Oncology	SSELL◷	1,100	$114.52	$126K	-9.0%	Open the original filing on SEC.gov
Oct 2	Vieira Roberto Wandenkol…	President, Oncology	MEXER◷	8,333	$21.63	$180.2K	+211.2%	Open the original filing on SEC.gov
Oct 2	Maduck Sean	See Remarks	MEXER◷◆	24,587	—	—	—	Open the original filing on SEC.gov
Oct 2	Maduck Sean	See Remarks	SSELL◷	8,744	$116.55	$1M	-46.8%	Open the original filing on SEC.gov
Oct 2	Maduck Sean	See Remarks	SSELL◷	15,843	$116.12	$1.8M	-45.9%	Open the original filing on SEC.gov
Oct 2	Maduck Sean	See Remarks	MEXER◷	24,587	$8.27	$203.3K	+247.4%	Open the original filing on SEC.gov
Oct 1	Lyon Joseph Douglas	See Remarks	MEXER◷◆	810	—	—	—	Open the original filing on SEC.gov
Oct 1	Lyon Joseph Douglas	See Remarks	SSELL◷	810	$115.40	$93.5K	-12.5%	Open the original filing on SEC.gov
Oct 1	Lyon Joseph Douglas	See Remarks	MEXER◷	810	$13.56	$11K	+14.2%	Open the original filing on SEC.gov
Oct 1	Maduck Sean	See Remarks	MEXER◷◆	413	—	—	—	Open the original filing on SEC.gov
Oct 1	Maduck Sean	See Remarks	SSELL◷	413	$115.54	$47.7K	-4.0%	Open the original filing on SEC.gov
Oct 1	Maduck Sean	See Remarks	MEXER◷	413	$8.27	$3.4K	+4.2%	Open the original filing on SEC.gov
Oct 1	Gunn Justin Frederick	See Remarks	AGRANT◆	100,000	—	—	—	Open the original filing on SEC.gov
Sep 24	Robb Gary Charles	Chief Business Officer	GGIFT	5,000	—	—	+32.1%	Open the original filing on SEC.gov
Sep 24	Robb Gary Charles	Chief Business Officer	GGIFT	5,000	—	—	+32.1%	Open the original filing on SEC.gov
Sep 24	Robb Gary Charles	Chief Business Officer	GGIFT	17,100	—	—	-54.9%	Open the original filing on SEC.gov
Sep 17	Robb Gary Charles	Chief Business Officer	MEXER◆	17,493	—	—	—	Open the original filing on SEC.gov
Sep 17	Robb Gary Charles	Chief Business Officer	MEXER	17,493	$8.27	$144.7K	+128.0%	Open the original filing on SEC.gov
Sep 16	Vieira Roberto Wandenkol…	President, Oncology	SSELL◷	296	$100.82	$29.8K	-7.0%	Open the original filing on SEC.gov
Sep 15	Wilson James N	Director	SSELL◷	2,800	$111.70	$312.8K	-0.3%	Open the original filing on SEC.gov
Sep 15	Wilson James N	Director	SSELL◷	400	$110.84	$44.3K	<0.1%	Open the original filing on SEC.gov
Sep 15	Wilson James N	Director	SSELL◷	6,800	$110.27	$749.8K	-0.6%	Open the original filing on SEC.gov
Sep 14	Lyon Joseph Douglas	See Remarks	MEXER◷◆	7,404	—	—	—	Open the original filing on SEC.gov
Sep 14	Lyon Joseph Douglas	See Remarks	MEXER◷◆	2,596	—	—	—	Open the original filing on SEC.gov
Sep 14	Lyon Joseph Douglas	See Remarks	SSELL◷	2,188	$114.12	$249.7K	-27.8%	Open the original filing on SEC.gov
Sep 14	Lyon Joseph Douglas	See Remarks	SSELL◷	7,812	$113.32	$885.3K	-49.8%	Open the original filing on SEC.gov
Sep 14	Lyon Joseph Douglas	See Remarks	MEXER◷	7,404	$13.56	$100.4K	+89.4%	Open the original filing on SEC.gov
Sep 14	Lyon Joseph Douglas	See Remarks	MEXER◷	2,596	$11.35	$29.5K	+45.7%	Open the original filing on SEC.gov
Sep 2	Maduck Sean	See Remarks	FTAX◷	117	$113.38	$13.3K	-1.2%	Open the original filing on SEC.gov
Sep 2	Mokari Atabak	Chief Financial Officer	FTAX	102	$113.38	$11.6K	-0.6%	Open the original filing on SEC.gov
Sep 2	Vieira Roberto Wandenkol…	President, Oncology	MEXER◷◆	58,333	—	—	—	Open the original filing on SEC.gov
Sep 2	Vieira Roberto Wandenkol…	President, Oncology	SSELL◷	1,225	$115.44	$141.4K	-22.4%	Open the original filing on SEC.gov
Sep 2	Vieira Roberto Wandenkol…	President, Oncology	SSELL◷	5,621	$114.58	$644K	-50.7%	Open the original filing on SEC.gov
Sep 2	Vieira Roberto Wandenkol…	President, Oncology	SSELL◷	1,606	$113.72	$182.6K	-12.7%	Open the original filing on SEC.gov
Sep 2	Vieira Roberto Wandenkol…	President, Oncology	SSELL◷	974	$112.40	$109.5K	-7.1%	Open the original filing on SEC.gov
Sep 2	Vieira Roberto Wandenkol…	President, Oncology	SSELL◷	1,537	$111.37	$171.2K	-10.1%	Open the original filing on SEC.gov
Sep 2	Vieira Roberto Wandenkol…	President, Oncology	SSELL◷	23,770	$110.70	$2.6M	-61.0%	Open the original filing on SEC.gov
Sep 2	Vieira Roberto Wandenkol…	President, Oncology	SSELL◷	23,600	$109.35	$2.6M	-37.7%	Open the original filing on SEC.gov
Sep 2	Vieira Roberto Wandenkol…	President, Oncology	MEXER◷	58,333	$21.63	$1.3M	+1,375%	Open the original filing on SEC.gov
Sep 2	Vieira Roberto Wandenkol…	President, Oncology	FTAX◷	102	$113.38	$11.6K	-2.4%	Open the original filing on SEC.gov
Sep 2	Robb Gary Charles	Chief Business Officer	FTAX	91	$113.38	$10.3K	-0.7%	Open the original filing on SEC.gov
Sep 2	Lyon Joseph Douglas	See Remarks	FTAX	72	$113.38	$8.2K	-1.3%	Open the original filing on SEC.gov
Sep 1	Maduck Sean	See Remarks	MEXER◷◆	25,000	—	—	—	Open the original filing on SEC.gov
Sep 1	Maduck Sean	See Remarks	AGRANT◷	150	—	—	+1.5%	Open the original filing on SEC.gov
Sep 1	Maduck Sean	See Remarks	AGRANT◷	150	$113.38	$17K	+1.5%	Open the original filing on SEC.gov
Sep 1	Maduck Sean	See Remarks	SSELL◷	2,281	$115.61	$263.7K	-18.9%	Open the original filing on SEC.gov
Sep 1	Maduck Sean	See Remarks	SSELL◷	10,989	$114.71	$1.3M	-47.7%	Open the original filing on SEC.gov
Sep 1	Maduck Sean	See Remarks	SSELL◷	11,730	$113.94	$1.3M	-33.8%	Open the original filing on SEC.gov
Sep 1	Maduck Sean	See Remarks	MEXER◷	25,000	$8.27	$206.8K	+256.3%	Open the original filing on SEC.gov
Sep 1	Guyer William	Chief Development…	AGRANT	164	—	—	+4.0%	Open the original filing on SEC.gov
Sep 1	Guyer William	Chief Development…	AGRANT	164	$113.38	$18.6K	+4.1%	Open the original filing on SEC.gov
Sep 1	Mokari Atabak	Chief Financial Officer	AGRANT	138	—	—	+0.9%	Open the original filing on SEC.gov
Sep 1	Mokari Atabak	Chief Financial Officer	AGRANT	138	$113.38	$15.6K	+0.9%	Open the original filing on SEC.gov
Sep 1	Vieira Roberto Wandenkol…	President, Oncology	AGRANT◷	138	—	—	+3.3%	Open the original filing on SEC.gov
Sep 1	Vieira Roberto Wandenkol…	President, Oncology	AGRANT◷	138	$113.38	$15.6K	+3.4%	Open the original filing on SEC.gov
Sep 1	Robb Gary Charles	Chief Business Officer	AGRANT	164	—	—	+1.2%	Open the original filing on SEC.gov
Sep 1	Robb Gary Charles	Chief Business Officer	AGRANT	164	$113.38	$18.6K	+1.2%	Open the original filing on SEC.gov
Sep 1	Lyon Joseph Douglas	See Remarks	AGRANT	130	—	—	+2.3%	Open the original filing on SEC.gov
Sep 1	Lyon Joseph Douglas	See Remarks	AGRANT	130	$113.38	$14.7K	+2.4%	Open the original filing on SEC.gov
Aug 26	Park Kimberly	Director	MEXER◆	30,000	—	—	—	Open the original filing on SEC.gov
Aug 26	Park Kimberly	Director	SSELL	26,685	$122.55	$3.3M	-100.0%	Open the original filing on SEC.gov
Aug 26	Park Kimberly	Director	FTAX	3,315	$122.09	$404.7K	-11.1%	Open the original filing on SEC.gov
Aug 26	Park Kimberly	Director	MEXER	30,000	$13.49	$404.7K	—	Open the original filing on SEC.gov
Aug 25	Maduck Sean	See Remarks	MEXER◷◆	30,955	—	—	—	Open the original filing on SEC.gov
Aug 25	Maduck Sean	See Remarks	SSELL◷	5,870	$126.06	$740K	-37.6%	Open the original filing on SEC.gov
Aug 25	Maduck Sean	See Remarks	SSELL◷	25,085	$125.47	$3.1M	-61.6%	Open the original filing on SEC.gov
Aug 25	Maduck Sean	See Remarks	MEXER◷	30,955	$11.35	$351.3K	+317.3%	Open the original filing on SEC.gov
Aug 18	Mahoney David L	Director	SSELL◷	400	$119.64	$47.9K	<0.1%	Open the original filing on SEC.gov
Aug 18	Mahoney David L	Director	SSELL◷	7,055	$118.88	$838.7K	-0.6%	Open the original filing on SEC.gov
Aug 18	Mahoney David L	Director	SSELL◷	91,167	$118.24	$10.8M	-7.4%	Open the original filing on SEC.gov
Aug 18	Mahoney David L	Director	SSELL◷	4,984	$117.47	$585.5K	-0.4%	Open the original filing on SEC.gov
Aug 17	Robb Gary Charles	Chief Business Officer	SSELL	10,000	$116.26	$1.2M	-20.1%	Open the original filing on SEC.gov
Aug 17	Robb Gary Charles	Chief Business Officer	GGIFT	125	—	—	-0.9%	Open the original filing on SEC.gov
Aug 14	Wilson James N	Director	SSELL◷	2,279	$112.64	$256.7K	-0.2%	Open the original filing on SEC.gov
Aug 14	Wilson James N	Director	SSELL◷	4,668	$111.44	$520.2K	-0.4%	Open the original filing on SEC.gov
Aug 14	Wilson James N	Director	SSELL◷	3,053	$110.49	$337.3K	-0.3%	Open the original filing on SEC.gov
Aug 14	Maduck Sean	See Remarks	MEXER◷◆	3,664	—	—	—	Open the original filing on SEC.gov

MEXER◷◆—

Maduck Sean · See RemarksNov 3

13,159 sh

SSELL◷$375.5K

Maduck Sean · See RemarksNov 3

4,542 sh @ $82.68 · -31.4% own

SSELL◷$706.8K

Maduck Sean · See RemarksNov 3

8,617 sh @ $82.02 · -37.3% own

MEXER◷$108.8K

Maduck Sean · See RemarksNov 3

13,159 sh @ $8.27 · +132.4% own

MEXER◷◆—

Vieira Roberto Wandenkol… · President, Oncolog…Nov 2

8,333 sh

SSELL◷$136.6K

Vieira Roberto Wandenkol… · President, Oncolog…Nov 2

1,676 sh @ $81.52 · -29.8% own

SSELL◷$537.4K

Vieira Roberto Wandenkol… · President, Oncolog…Nov 2

6,657 sh @ $80.73 · -54.2% own

MEXER◷$180.2K

Vieira Roberto Wandenkol… · President, Oncolog…Nov 2

8,333 sh @ $21.63 · +211.2% own

MEXER◷◆—

Maduck Sean · See RemarksNov 2

11,841 sh

SSELL◷$964.1K

Maduck Sean · See RemarksNov 2

11,841 sh @ $81.42 · -54.4% own

MEXER◷$97.9K

Maduck Sean · See RemarksNov 2

11,841 sh @ $8.27 · +119.2% own

SSELL◷$34.9K

Wilson James N · DirectorOct 15

300 sh @ $116.30 · <0.1% own

SSELL◷$351.5K

Wilson James N · DirectorOct 15

3,046 sh @ $115.39 · -0.3% own

SSELL◷$761.7K

Wilson James N · DirectorOct 15

6,654 sh @ $114.48 · -0.6% own

MEXER◷◆—

Lyon Joseph Douglas · See RemarksOct 2

5,833 sh

MEXER◷◆—

Lyon Joseph Douglas · See RemarksOct 2

3,357 sh

SSELL◷$552.9K

Lyon Joseph Douglas · See RemarksOct 2

4,744 sh @ $116.54 · -45.5% own

SSELL◷$514.4K

Lyon Joseph Douglas · See RemarksOct 2

4,446 sh @ $115.70 · -29.9% own

MEXER◷$112.3K

Lyon Joseph Douglas · See RemarksOct 2

5,833 sh @ $19.26 · +64.5% own

MEXER◷$45.5K

Lyon Joseph Douglas · See RemarksOct 2

3,357 sh @ $13.56 · +59.1% own

MEXER◷◆—

Vieira Roberto Wandenkol… · President, Oncolog…Oct 2

8,333 sh

SSELL◷$600.1K

Vieira Roberto Wandenkol… · President, Oncolog…Oct 2

5,147 sh @ $116.59 · -56.6% own

SSELL◷$241.4K

Vieira Roberto Wandenkol… · President, Oncolog…Oct 2

2,086 sh @ $115.73 · -18.7% own

SSELL◷$126K

Vieira Roberto Wandenkol… · President, Oncolog…Oct 2

1,100 sh @ $114.52 · -9.0% own

MEXER◷$180.2K

Vieira Roberto Wandenkol… · President, Oncolog…Oct 2

8,333 sh @ $21.63 · +211.2% own

MEXER◷◆—

Maduck Sean · See RemarksOct 2

24,587 sh

SSELL◷$1M

Maduck Sean · See RemarksOct 2

8,744 sh @ $116.55 · -46.8% own

SSELL◷$1.8M

Maduck Sean · See RemarksOct 2

15,843 sh @ $116.12 · -45.9% own

MEXER◷$203.3K

Maduck Sean · See RemarksOct 2

24,587 sh @ $8.27 · +247.4% own

MEXER◷◆—

Lyon Joseph Douglas · See RemarksOct 1

810 sh

SSELL◷$93.5K

Lyon Joseph Douglas · See RemarksOct 1

810 sh @ $115.40 · -12.5% own

MEXER◷$11K

Lyon Joseph Douglas · See RemarksOct 1

810 sh @ $13.56 · +14.2% own

MEXER◷◆—

Maduck Sean · See RemarksOct 1

413 sh

SSELL◷$47.7K

Maduck Sean · See RemarksOct 1

413 sh @ $115.54 · -4.0% own

MEXER◷$3.4K

Maduck Sean · See RemarksOct 1

413 sh @ $8.27 · +4.2% own

AGRANT◆—

Gunn Justin Frederick · See RemarksOct 1

100,000 sh

GGIFT—

Robb Gary Charles · Chief Business…Sep 24

5,000 sh · +32.1% own

GGIFT—

Robb Gary Charles · Chief Business…Sep 24

5,000 sh · +32.1% own

GGIFT—

Robb Gary Charles · Chief Business…Sep 24

17,100 sh · -54.9% own

MEXER◆—

Robb Gary Charles · Chief Business…Sep 17

17,493 sh

MEXER$144.7K

Robb Gary Charles · Chief Business…Sep 17

17,493 sh @ $8.27 · +128.0% own

SSELL◷$29.8K

Vieira Roberto Wandenkol… · President, Oncolog…Sep 16

296 sh @ $100.82 · -7.0% own

SSELL◷$312.8K

Wilson James N · DirectorSep 15

2,800 sh @ $111.70 · -0.3% own

SSELL◷$44.3K

Wilson James N · DirectorSep 15

400 sh @ $110.84 · <0.1% own

SSELL◷$749.8K

Wilson James N · DirectorSep 15

6,800 sh @ $110.27 · -0.6% own

MEXER◷◆—

Lyon Joseph Douglas · See RemarksSep 14

7,404 sh

MEXER◷◆—

Lyon Joseph Douglas · See RemarksSep 14

2,596 sh

SSELL◷$249.7K

Lyon Joseph Douglas · See RemarksSep 14

2,188 sh @ $114.12 · -27.8% own

SSELL◷$885.3K

Lyon Joseph Douglas · See RemarksSep 14

7,812 sh @ $113.32 · -49.8% own

MEXER◷$100.4K

Lyon Joseph Douglas · See RemarksSep 14

7,404 sh @ $13.56 · +89.4% own

MEXER◷$29.5K

Lyon Joseph Douglas · See RemarksSep 14

2,596 sh @ $11.35 · +45.7% own

FTAX◷$13.3K

Maduck Sean · See RemarksSep 2

117 sh @ $113.38 · -1.2% own

FTAX$11.6K

Mokari Atabak · Chief Financial…Sep 2

102 sh @ $113.38 · -0.6% own

MEXER◷◆—

Vieira Roberto Wandenkol… · President, Oncolog…Sep 2

58,333 sh

SSELL◷$141.4K

Vieira Roberto Wandenkol… · President, Oncolog…Sep 2

1,225 sh @ $115.44 · -22.4% own

SSELL◷$644K

Vieira Roberto Wandenkol… · President, Oncolog…Sep 2

5,621 sh @ $114.58 · -50.7% own

SSELL◷$182.6K

Vieira Roberto Wandenkol… · President, Oncolog…Sep 2

1,606 sh @ $113.72 · -12.7% own

SSELL◷$109.5K

Vieira Roberto Wandenkol… · President, Oncolog…Sep 2

974 sh @ $112.40 · -7.1% own

SSELL◷$171.2K

Vieira Roberto Wandenkol… · President, Oncolog…Sep 2

1,537 sh @ $111.37 · -10.1% own

SSELL◷$2.6M

Vieira Roberto Wandenkol… · President, Oncolog…Sep 2

23,770 sh @ $110.70 · -61.0% own

SSELL◷$2.6M

Vieira Roberto Wandenkol… · President, Oncolog…Sep 2

23,600 sh @ $109.35 · -37.7% own

MEXER◷$1.3M

Vieira Roberto Wandenkol… · President, Oncolog…Sep 2

58,333 sh @ $21.63 · +1,375% own

FTAX◷$11.6K

Vieira Roberto Wandenkol… · President, Oncolog…Sep 2

102 sh @ $113.38 · -2.4% own

FTAX$10.3K

Robb Gary Charles · Chief Business…Sep 2

91 sh @ $113.38 · -0.7% own

FTAX$8.2K

Lyon Joseph Douglas · See RemarksSep 2

72 sh @ $113.38 · -1.3% own

MEXER◷◆—

Maduck Sean · See RemarksSep 1

25,000 sh

AGRANT◷—

Maduck Sean · See RemarksSep 1

150 sh · +1.5% own

AGRANT◷$17K

Maduck Sean · See RemarksSep 1

150 sh @ $113.38 · +1.5% own

SSELL◷$263.7K

Maduck Sean · See RemarksSep 1

2,281 sh @ $115.61 · -18.9% own

SSELL◷$1.3M

Maduck Sean · See RemarksSep 1

10,989 sh @ $114.71 · -47.7% own

SSELL◷$1.3M

Maduck Sean · See RemarksSep 1

11,730 sh @ $113.94 · -33.8% own

MEXER◷$206.8K

Maduck Sean · See RemarksSep 1

25,000 sh @ $8.27 · +256.3% own

AGRANT—

Guyer William · Chief Development…Sep 1

164 sh · +4.0% own

AGRANT$18.6K

Guyer William · Chief Development…Sep 1

164 sh @ $113.38 · +4.1% own

AGRANT—

Mokari Atabak · Chief Financial…Sep 1

138 sh · +0.9% own

AGRANT$15.6K

Mokari Atabak · Chief Financial…Sep 1

138 sh @ $113.38 · +0.9% own

AGRANT◷—

Vieira Roberto Wandenkol… · President, Oncolog…Sep 1

138 sh · +3.3% own

AGRANT◷$15.6K

Vieira Roberto Wandenkol… · President, Oncolog…Sep 1

138 sh @ $113.38 · +3.4% own

AGRANT—

Robb Gary Charles · Chief Business…Sep 1

164 sh · +1.2% own

AGRANT$18.6K

Robb Gary Charles · Chief Business…Sep 1

164 sh @ $113.38 · +1.2% own

AGRANT—

Lyon Joseph Douglas · See RemarksSep 1

130 sh · +2.3% own

AGRANT$14.7K

Lyon Joseph Douglas · See RemarksSep 1

130 sh @ $113.38 · +2.4% own

MEXER◆—

Park Kimberly · DirectorAug 26

30,000 sh

SSELL$3.3M

Park Kimberly · DirectorAug 26

26,685 sh @ $122.55 · -100.0% own

FTAX$404.7K

Park Kimberly · DirectorAug 26

3,315 sh @ $122.09 · -11.1% own

MEXER$404.7K

Park Kimberly · DirectorAug 26

30,000 sh @ $13.49

MEXER◷◆—

Maduck Sean · See RemarksAug 25

30,955 sh

SSELL◷$740K

Maduck Sean · See RemarksAug 25

5,870 sh @ $126.06 · -37.6% own

SSELL◷$3.1M

Maduck Sean · See RemarksAug 25

25,085 sh @ $125.47 · -61.6% own

MEXER◷$351.3K

Maduck Sean · See RemarksAug 25

30,955 sh @ $11.35 · +317.3% own

SSELL◷$47.9K

Mahoney David L · DirectorAug 18

400 sh @ $119.64 · <0.1% own

SSELL◷$838.7K

Mahoney David L · DirectorAug 18

7,055 sh @ $118.88 · -0.6% own

SSELL◷$10.8M

Mahoney David L · DirectorAug 18

91,167 sh @ $118.24 · -7.4% own

SSELL◷$585.5K

Mahoney David L · DirectorAug 18

4,984 sh @ $117.47 · -0.4% own

SSELL$1.2M

Robb Gary Charles · Chief Business…Aug 17

10,000 sh @ $116.26 · -20.1% own

GGIFT—

Robb Gary Charles · Chief Business…Aug 17

125 sh · -0.9% own

SSELL◷$256.7K

Wilson James N · DirectorAug 14

2,279 sh @ $112.64 · -0.2% own

SSELL◷$520.2K

Wilson James N · DirectorAug 14

4,668 sh @ $111.44 · -0.4% own

SSELL◷$337.3K

Wilson James N · DirectorAug 14

3,053 sh @ $110.49 · -0.3% own

MEXER◷◆—

Maduck Sean · See RemarksAug 14

3,664 sh

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

5 of 158 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 1,759 business days late.

Form 4 filings made after the two-business-day deadline, with the transaction date, the filing date and the number of business days between them.
Traded	Filed	Insider	Past deadline	Largest line	Source
May 15, 2018	Jun 1, 2025	Maduck SeanSee Remarks	1,759days · about 7 years	$38.8K	Filing ↗
Jan 27, 2025	Apr 22, 2025	Robb Gary CharlesChief Business Officer	58days · about 3 months	—	Filing ↗
Jun 12, 2025	Aug 4, 2025	Maduck SeanSee Remarks	33days · about 2 months	$1.9M	Filing ↗
May 27	Jul 7	Robb Gary CharlesChief Business Officer	25days	—	Filing ↗
Jan 8	Feb 12	Maduck SeanSee Remarks	22days	—	Filing ↗

Maduck SeanSee Remarks

1,759days · about 7 years

Traded May 15, 2018 · filed Jun 1, 2025Filing ↗

Robb Gary CharlesChief Business Officer

58days · about 3 months

Traded Jan 27, 2025 · filed Apr 22, 2025Filing ↗

Maduck SeanSee Remarks

33days · about 2 months

Traded Jun 12, 2025 · filed Aug 4, 2025Filing ↗

Robb Gary CharlesChief Business Officer

25days

Traded May 27 · filed Jul 7Filing ↗

Maduck SeanSee Remarks

22days

Traded Jan 8 · filed Feb 12Filing ↗

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More biotech & pharma companies

Other issuers in the same industry with insider filings on record.

Whole sector →